These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 9010112)

  • 41. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amplification and expression of the human cyclin D gene in esophageal cancer.
    Jiang W; Kahn SM; Tomita N; Zhang YJ; Lu SH; Weinstein IB
    Cancer Res; 1992 May; 52(10):2980-3. PubMed ID: 1533816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin D1 gene expression in human cervical neoplasia.
    Nichols GE; Williams ME; Gaffey MJ; Stoler MH
    Mod Pathol; 1996 Apr; 9(4):418-25. PubMed ID: 8729983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma.
    Frierson HF; Gaffey MJ; Zukerberg LR; Arnold A; Williams ME
    Mod Pathol; 1996 Jul; 9(7):725-30. PubMed ID: 8832554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
    de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
    Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
    Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
    Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PPFIA1 and CCND1 are frequently coamplified in breast cancer.
    Dancau AM; Wuth L; Waschow M; Holst F; Krohn A; Choschzick M; Terracciano L; Politis S; Kurtz S; Lebeau A; Friedrichs K; Wencke K; Monni O; Simon R
    Genes Chromosomes Cancer; 2010 Jan; 49(1):1-8. PubMed ID: 19787783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
    Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
    Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q.
    Jin Y; Höglund M; Jin C; Martins C; Wennerberg J; Akervall J; Mandahl N; Mitelman F; Mertens F
    Genes Chromosomes Cancer; 1998 Aug; 22(4):312-20. PubMed ID: 9669669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies.
    Miyamoto R; Uzawa N; Nagaoka S; Nakakuki K; Hirata Y; Amagasa T
    Cancer; 2002 Nov; 95(10):2152-9. PubMed ID: 12412169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
    Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
    Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.
    Hui R; Campbell DH; Lee CS; McCaul K; Horsfall DJ; Musgrove EA; Daly RJ; Seshadri R; Sutherland RL
    Oncogene; 1997 Sep; 15(13):1617-23. PubMed ID: 9380415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CCND1 amplification predicts sensitivity to chemotherapy and chemoradiotherapy in head and neck squamous cell carcinoma.
    Ishiguro R; Fujii M; Yamashita T; Tashiro M; Tomita T; Ogawa K; Kameyama K
    Anticancer Res; 2003; 23(6D):5213-20. PubMed ID: 14981992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.
    Janssen JW; Imoto I; Inoue J; Shimada Y; Ueda M; Imamura M; Bartram CR; Inazawa J
    J Hum Genet; 2002; 47(9):460-4. PubMed ID: 12202983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1.
    Jhang JS; Narayan G; Murty VV; Mansukhani MM
    Cancer Genet Cytogenet; 2004 Mar; 149(2):114-9. PubMed ID: 15036886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
    Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
    Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
    Bartkova J; Lukas J; Strauss M; Bartek J
    J Pathol; 1994 Mar; 172(3):237-45. PubMed ID: 8195927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.